769 completed, 214 unknown, 203 terminated, 181 recruiting. 1639 Phase 2, 287 Phase 1, 66 Phase 3.
Follow Paclitaxel: new trials by email Literature Review of Paclitaxel trials Research Report on Paclitaxel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HEADWATERS: Gemcitabine vs Paclitaxel in Metastatic Triple-Negative Breast Cancer in Women of African Ancestry. Gemcitabine (1000 mg/m^2), Paclitaxel 80 mg/m2 weekly - Triple Negative Breast Cancer, Metastatic Triple-negative Breast Cancer | Phase 2 | Not yet recruiting | The University of The West Indies | 750 | 2027-06-01 | 2026-09-22 |
| Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer AST-201, Paclitaxel, Carboplatin - Advanced Ovarian Cancer | Phase 2 | Not yet recruiting | Aston Sci. Inc. | 98 | 2027-06-01 | 2026-10-27 |
| A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck Cemiplimab, Fianlimab, Carboplatin - Squamous Cell Carcinoma | Phase 2 | Not yet recruiting | University of Chicago | 90 | 2027-02-07 | 2026-01-20 |
| Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer losartan, Paclitaxel - Platinum Resistant Ovarian Cancer | Phase 2 | Not yet recruiting | Massachusetts General Hospital | 27 | 2027-02-01 | 2026-09-22 |
| Immune Checkpoint Blockade and Chemotherapy With or Without Fecal Microbiota Transplant in Advanced Non-Small Cell Lung Cancer LND101, Carboplatin, Pemetrexed - Non Small Cell Lung Cancer | Phase 2 | Not yet recruiting | Canadian Cancer Trials Group | 160 | 2026-12-31 | 2026-10-27 |
| Aspirin and PAClitaxel in Head & Neck Squamous Cell Carcinoma Aspirin, Paclitaxel - Head and Neck (HNSCC), Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M) | Phase 2 | Not yet recruiting | Washington University School of Medicine | 40 | 2026-12-31 | 2026-10-28 |
| Zanzalintinib and Pembrolizumab in First-Line Maintenance for Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC) Carboplatin, Paclitaxel, Nab-paclitaxel - Squamous Non-Small Cell Lung Cancer (NSCLC) | Phase 2 | Not yet recruiting | Exelixis | 60 | 2026-12-15 | 2026-09-29 |
| A Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage Non-Small Cell Lung Cancer (ROSETTA Lung-220) Pumitamig, Carboplatin, Cisplatin - Early-Stage Non-Small Cell Lung Cancer | Phase 2 | Not yet recruiting | Bristol-Myers Squibb | 80 | 2026-11-30 | 2026-10-13 |
| Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC) azacytidine, carboplatin, paclitaxel - Non-small Cell Lung Cancer (NSCLC), Carcinoma, Non-Small Cell Lung | Phase 1 / Phase 2 | Suspended | National Cancer Institute (NCI) | 60 | 2026-11-04 | 2026-10-30 |
| Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer Cemiplimab, Carboplatin + Pemetrexed/Paclitaxel, Cisplatin - Non-Small Cell Lung Cancer | Phase 2 | Not yet recruiting | Medical University of South Carolina | 38 | 2026-11-01 | 2026-07-22 |
| Lurbinectedin Plus Paclitaxel Versus Paclitaxel in Patients With Previously Treated Small Cell Lung Cancer Lurbinectedin, Paclitaxel - Carcinoma, Small Cell Lung | Phase 2 | Not yet recruiting | Yonsei University | 69 | 2026-11-01 | 2026-09-04 |
| Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain Mets Ivonescimab, Carboplatin, Pemetrexed - Non Small Cell Lung Cancer | Phase 2 | Not yet recruiting | European Organisation for Research and Treatment of Cancer - EORTC | 158 | 2026-11-01 | 2026-06-04 |
| A Phase II Study of HLX22 in Combination With Trastuzumab and Chemotherapy in HER2-Positive Locally Advanced or Metastatic Breast Cancer Patients HLX22, Trastuzumab, Capecitabine - HER2 + Breast Cancer | Phase 2 | Not yet recruiting | Shanghai Henlius Biotech | 90 | 2026-10-31 | 2026-09-17 |
| An Open, Multicenter Phase II Clinical Trial of SHR-A2009 Combined With Other Anti-tumor Therapies for Perioperative Treatment of Resectable Non-small Cell Lung Cancer. adebrelimab + SHR-A2009, paclitaxel or pemetrexed combined with carboplatin +adebrelimab, adebrelimab - Non-small Cell Lung Cancer | Phase 2 | Not yet recruiting | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 660 | 2026-10-30 | 2026-10-07 |
| A Clinical Trial of MK-2010 Alone and With Other Treatments in Participants With Advanced Solid Tumors (MK-2010-002) MK-2010, Pembrolizumab, 5-Fluorouracil - Malignant Neoplam, Advanced Solid Tumors | Phase 2 | Not yet recruiting | Merck Sharp & Dohme LLC | 480 | 2026-10-27 | 2026-10-08 |
| Quad Shot Radiotherapy Combined With Tislelizumab and Platinum-Based Chemotherapy Before Surgery for Stage II-III Non-Small Cell Lung Cancer Quad Shot Radiotherapy, Tislelizumab, Carboplatin or cisplatin - Non-Small Cell Lung Cancer | Phase 2 | Not yet recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 12 | 2026-10-10 | 2026-09-29 |
| Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer Paclitaxel, Cisplatin, Bioferon - Ovarian Cancer | Phase 2 | Not yet recruiting | Kalinski, Pawel, MD, PhD | 28 | 2026-10-01 | 2026-10-13 |
| Tailored Neoadjuvant Chemoimmunotherapy for Stage I TNBC Pembrolizumab, Paclitaxel (Chemotherapy), Carboplatin - Triple-Negative Breast Cancer (TNBC) | Phase 2 | Not yet recruiting | University of Texas Southwestern Medical Center | 60 | 2026-10-01 | 2026-08-26 |
| US/PA/E Imaging for Early Identification of Tumor Response in Patients With Stage II-III Triple Negative Breast Cancer Receiving Neoadjuvant Immunotherapy and Chemotherapy Elastography, Magnetic Resonance Imaging, Photoacoustic Imaging - Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | Phase 2 | Not yet recruiting | Emory University | 32 | 2026-10-01 | 2026-10-07 |
| Perioperative Adebrelimab for Locally Advanced Cervical Cancer Adebrelimab, Paclitaxel, Cisplatin - Locally Advanced Cervical Cancer | Phase 2 | Not yet recruiting | Anhui Provincial Hospital | 35 | 2026-10-01 | 2026-09-10 |
Showing 20 of 1639. Sign in to see all of them.
Breast Neoplasms (331) · Carcinoma, Non-Small-Cell Lung (276) · Ovarian Neoplasms (175) · Lung Neoplasms (131) · Esophageal Neoplasms (85) · Stomach Neoplasms (84) · Triple Negative Breast Neoplasms (82) · Fallopian Tube Neoplasms (75) · Squamous Cell Carcinoma of Head and Neck (73) · Neoplasm Metastasis (70) · Esophageal Squamous Cell Carcinoma (59) · Head and Neck Neoplasms (55) · Neoplasms (55) · Carcinoma, Ovarian Epithelial (54) · Endometrial Neoplasms (45)
National Cancer Institute (NCI) (80) · M.D. Anderson Cancer Center (44) · Bristol-Myers Squibb (26) · Memorial Sloan Kettering Cancer Center (26) · Merck Sharp & Dohme LLC (22) · Hoffmann-La Roche (21) · Eli Lilly and Company (20) · Alliance for Clinical Trials in Oncology (19) · Eastern Cooperative Oncology Group (19) · Sun Yat-sen University (18) · Genentech, Inc. (17) · SWOG Cancer Research Network (17) · AstraZeneca (16) · Dana-Farber Cancer Institute (16) · Fox Chase Cancer Center (14)
United States (873) · China (274) · Spain (158) · France (148) · South Korea (136) · Italy (119) · Germany (114) · United Kingdom (106) · Canada (105) · Australia (75) · Belgium (68) · Taiwan (68) · Poland (65) · Japan (51) · Netherlands (47)
Mariano Provencio, MD (7) · Corey J. Langer, MD (5) · John D. Hainsworth, MD (5) · Aminah Jatoi, MD (4) · Francesco Perrone, M.D., Ph.D. (4)
PMID 37185961, PMID 21502559, PMID 25092775, PMID 35170751, PMID 22646630, PMID 24794243, PMID 25057165, PMID 25366678, PMID 25403584, PMID 26313683, PMID 28434660, PMID 30207593, PMID 30976202, PMID 33154826, PMID 33736679, PMID 38129778, PMID 41531940, PMID 41811823, PMID 10091726, PMID 10210538, PMID 10235156, PMID 10555755, PMID 10623700, PMID 10628376, PMID 10655437, PMID 10694544, PMID 10793106, PMID 10830142, PMID 11085525, PMID 11123390, PMID 11208820, PMID 11230468, PMID 11282421, PMID 11309294, PMID 11331762, PMID 11352950, PMID 11459964, PMID 11533692, PMID 11573045, PMID 11813623, PMID 11870157, PMID 11919245, PMID 12056703, PMID 12167786, PMID 12205100, PMID 12217790, PMID 12241653, PMID 12393992, PMID 12460789, PMID 12581572
U10CA180868 (22), 2023 (18), U10CA032102 (18), 2018 (15), 2014 (13), 2016 (12), 2009 (11), 2025 (11), U10CA031946 (11), 2017 (10), U10CA021115 (10), U10CA027469 (10), U10CA180820 (9), 2019 (7), U10CA021661 (7)